Southeast Asia's largest professional network for healthcare professionals. Connecting 400K+ doctors across 7 countries.
Monitoring Docquity offers critical intelligence on the professional behavior, learning trends, and clinical needs of a massive, engaged network of healthcare practitioners in Asia. The platform's data provides unique signals on the adoption of new treatments and the impact of digital engagement strategies, making it an essential resource for competitive intelligence and market analysis in the pharmaceutical and life sciences sectors.
Docquity is a key company within the Healthtech & Biotech channel.Its official updates regularly contribute to how users track developments in this space, including strategic moves, partnerships, and technology shifts.
4 signals tracked to date in this channel.
View channelDocquity operates in a global market where SigFact tracks official signals from primary sources to provide timely, verified intelligence.
See recent signals in this marketDocquity launches Engage™, an AI-powered HCP intelligence engine for life sciences, to provide deeper insights into healthcare professional behavior and engagement.
Docquity Launches AI-Powered HCP Intelligence Engine for Life Sciences
Docquity and Novartis partner to improve retinal health education and care standards for healthcare professionals and patients in Malaysia.
Docquity and Novartis Partner on Retinal Health in Malaysia
Docquity deploys AI platform at Indonesian hospital to enhance medical knowledge and patient care, improving diagnostic capabilities and treatment planning.
Docquity's AI Platform Enhances Care at Indonesian Hospital
Docquity launches AI-powered Docquity Engage™ engine for life sciences in Asia, reducing HCP touchpoint costs by 80% in Philippine pilot.
Docquity Launches AI Engine to Optimize HCP Engagement
Docquity launches Engage™, an AI-powered HCP intelligence engine for life sciences, to provide deeper insights into healthcare professional behavior and engagement.
Docquity Launches AI-Powered HCP Intelligence Engine for Life Sciences
Docquity has launched Engage™, an AI and insights-powered Healthcare Professional (HCP) intelligence engine specifically designed for the life sciences industry. This new platform aims to provide deeper understanding and actionable insights into HCP behavior and engagement, enabling life sciences companies to optimize their strategies and improve outcomes. The engine leverages advanced AI to analyze complex data, offering a more sophisticated approach to HCP intelligence.
Docquity and Novartis partner to improve retinal health education and care standards for healthcare professionals and patients in Malaysia.
Docquity and Novartis Partner on Retinal Health in Malaysia
Docquity has entered into a partnership with Novartis to address retinal health challenges in Malaysia. This collaboration will leverage Docquity's platform to educate healthcare professionals and patients about various retinal conditions, their early detection, and management. The initiative aims to improve the standard of care for eye diseases in the region.
Docquity deploys AI platform at Indonesian hospital to enhance medical knowledge and patient care, improving diagnostic capabilities and treatment planning.
Docquity's AI Platform Enhances Care at Indonesian Hospital
Docquity's AI platform has been deployed at RSUD Umar Wirahadikusumah Sumedang, an Indonesian hospital, to enhance medical knowledge and patient care. The implementation aims to provide healthcare professionals with advanced tools and insights, improving diagnostic capabilities and treatment planning. This deployment marks a step forward in leveraging AI for better healthcare delivery in Indonesia.
Docquity launches AI-powered Docquity Engage™ engine for life sciences in Asia, reducing HCP touchpoint costs by 80% in Philippine pilot.
Docquity Launches AI Engine to Optimize HCP Engagement
Docquity has launched Docquity Engage™, an AI-powered market intelligence engine that provides life sciences companies with real-time insights into healthcare professional behavior, optimizing engagement and reducing costs, as demonstrated by an 80% cost reduction in the Philippines.
Major Japanese pharma company focused on urology, oncology, and transplantation
Anglo-Swedish pharma company with strong oncology and rare disease pipeline
China's largest global biotech company focused on innovative oncology medicines
India's largest biopharmaceutical company and global biosimilars leader
Digital therapeutics and remote patient monitoring platform
Global biotech leader in plasma-derived therapies and vaccines
Follow this company, add it to your watchlist, or explore its signal stream to stay informed.